Source: http://health.yahoo.net/news/s/nm/astrazeneca-settles-crestor-patent-row-with-generics-firms
Wednesday, 27 March 2013
AstraZeneca settles Crestor patent row with generics firms
LONDON (Reuters) - AstraZeneca has settled a legal fight over its top-selling cholesterol drug Crestor with generics companies, protecting revenues in the all-important U.S. market until 2016. Under the agreement, Watson and Egis concede that the ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.